Abstract
Prior work in these laboratories identified (±)-5-hydroxy-6-methyl-2-(di-n-propylamino)tetralin as a dopaminergic agonist prodrug. The ortho methyl hydroxy aromatic substitution pattern in this molecule has now been incorporated into the aporphine ring system to give a congener of the dopaminergic agonist apomorphine in which the position 10 OH group has been replaced by methyl. Preparation of the target compound involved acid-catalyzed rearrangement of the 3-(1-phenyltetrazolyl) ether of morphine and subsequent molecular modification of the product, the 10-(1-phenyltetrazolyl) ether of (R)-(-)-apomorphine. Surprisingly, the target compound elicited no responses in any assays for effects at dopamine receptors, but rather it displayed pharmacological properties consistent with its being a serotonergic agonist with a high degree of selectivity for 5-HT1A receptors similar to the serotonergic agonist 8-hydroxy-2-(di-n-propylamino)tetralin. © 1988, American Chemical Society. All rights reserved.
Cite
CITATION STYLE
Cannon, J. G., Mohan, P., Bojarski, J., Long, J. P., Bhatnagar, R. K., Leonard, P. A., … Chatterjee, T. K. (1988). (R)-(-)-10-Methyl-11-hydroxyaporphine: A Highly Selective Serotonergic Agonist. Journal of Medicinal Chemistry, 31(2), 313–318. https://doi.org/10.1021/jm00397a007
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.